Prof. Dr. Ozan Cem Güler Özgeçmiş Sayfası

1

Prostat Kanseri Radyoterapisinde PSMA-PET Güvenilirliği ve Kısıtlılığı, nükleer tıp seminerleri, 1(0), 2023 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

2

The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy, Eur J Nucl Med Mol Imaging, 50(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Ezgi Oymak, Prof. Dr. Mehmet Reyhan

3

Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study, Journal of Pseudo-Differential Operators and Applications, 31(3), 2023 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Oymak E, Yazici G, Akagunduz Oo, Cetinayak O

4

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. In regard to Rajwa et al, European Urology Oncology, 2023(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler

5

Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients, Reports of Practical Oncology and Radiotherapy, 4(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Bozca R, Oymak E, Prof. Dr. Ozan Cem Güler

6

Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy, Medical Dosimetry, 48(1), 2023 SCI / SCI EXPANDED

Ezgi Oymak 1, Prof. Dr. Erkan Topkan, Recep Bozca 2, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

7

The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 184(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Erbay G, Oymak E, Prof. Dr. Ozan Cem Güler

8

Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(5), 2023 SCI / SCI EXPANDED

Yavas G, Prof. Dr. Ozan Cem Güler, Gultekin M, Oymak E, Yuce Sari S

9

The Effect of Bladder Volume on Three-dimensional Vaginal Cuff Brachytherapy Planning, Turk Onkoloji Dergisi-Turkish Journal of Oncology, 0(0), 2023 SSCI

Duru Birgi S, Prof. Dr. Ozan Cem Güler, Babayigit Y, Arslan Y, Akyürek S.

10

Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients, PROSTATE, 83(12), 2023 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler

11

Longer treatment time and lower radiation doses?an alternative for Graves? ophthalmopathy treatment, STRAHLENTHERAPIE UND ONKOLOGIE, 198(7), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler

12

Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. In Regard to Harmon et al., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 112(2), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

13

Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(1), 2022 SCI / SCI EXPANDED

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

14

Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes, the journal of obstetrics and gynecological researh, 48(7), 2022 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Oymak E, Gultekin M, Yigit E

15

The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy, RADIOTHERAPY AND ONCOLOGY, 173(0), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler, Oymak E

16

Dosimetric Comparison of Volumetric Arc Therapy Methods for Stereotactic Body Radiotherapy in Liver Metastasis, Turkish journal of oncology, 37(4), 2022 SSCI

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

17

Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002, European Urology Oncology, 5(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

18

There is no doubt about the winner of the lion?rabbit fight, PROSTATE, 82(12), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

19

The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 42(6), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Gultekin M, Yavas G, Oymak E, Yuce Sari S

20

Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 198(10), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Hurmuz P, Yavas G, Tilki B

21

Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al., Clinical Breast Cancer, 22(3), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

22

Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy., Journal of Pseudo-Differential Operators and Applications, 198(3), 2022 SCI / SCI EXPANDED

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

23

Re: Francolini et al.: Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis., CLINICAL ONCOLOGY, 34(1), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

24

The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma, Clinical & Translational Oncology, 24(8), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Hurmuz P, Prof. Dr. Ozan Cem Güler, Yavas G, Tilki B

25

Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 199(5), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B, Yavas G

26

Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial, EUROPEAN JOURNAL OF CANCER, 167(0), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

27

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54, European Urology Oncology, 5(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, İsci O., Prof. Dr. Hüseyin Cem Önal

28

Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma, Journal of Pseudo-Differential Operators and Applications, 107(2), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Oymak E, Hurmuz P, Yavas G, Tilki B.

29

Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease., CLINICAL ONCOLOGY, 34(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

30

Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. In regard to De Virgilio et al, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(9), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

31

Prognostic factors of endometrial cancer in elderly patient group and their effects on survival, north clin İstanbul, 0(0), 2021 ESCI

Songül Alemdaroğlu, Doç. Dr. Gülşen Doğan Durdağ, Şafak Yılmaz Baran, Seda Yüksel Şimşek, Dr. Öğr. Üyesi Selçuk Yetkinel

32

Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients, PROSTATE, 108(3), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Hurmuz P

33

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 81(9), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Kose F, Ozyigit G, Aksoy S, Oymak E

34

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al., MEDICAL ONCOLOGY, 38(7), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler

35

Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy, ACTA ONCOLOGICA, 60(9), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yavas G, Oymak E, Duru Birgi S

36

Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy, Future Oncology, 17(25), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yavas G, Prof. Dr. Ozan Cem Güler, Yigit E

37

Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerIn Regard to Deek et al. , INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(5), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Oymak E

38

The clinical outcomes of ovarian cancer in patients with brain metastasis, EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 42(5), 2021 SCI / SCI EXPANDED

Seda Yuksel Simsek1, Prof. Dr. Ozan Cem Güler, Gülşen Doğan Durdag1, Sezin Yüce Sari3, Melis Gultekin3

39

NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer: In Regard to Hall et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(2), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

40

Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study, CLINICAL NUCLEAR MEDICINE, 46(6), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Akgun Z, Atalar B, İgdem S

41

Prognostic factors of endometrial cancer in elderly patient group and their effects on survival., north clinical istanbul, 8(4), 2021 SCI / SCI EXPANDED

Alemdaroglu S, Durdag Gd, Baran Sy, Simsek Sy, Yetkinel S

42

Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 11(0), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B

43

Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.: in regard to Lin et al. , CLINICAL ONCOLOGY, 33(0), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

44

Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 31(2), 2021 SCI / SCI EXPANDED

Gultekin M, Beduk Esen Cs, Balci B, Alanyali S, Akkus Yildirim B

45

The clinical outcomes of ovarian cancer in patients with brain metatstasis, ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 0(0), 2021 SCI / SCI EXPANDED

Seda Yüksel Şimşek, Prof. Dr. Ozan Cem Güler, Doç. Dr. Gülşen Doğan Durdağ, Sezin Yüce Sarı, Murat Gültekin

46

Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(0), 2020 SCI / SCI EXPANDED

Doç. Dr. Neşe Torun, Ezgi Oymak, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ozan Cem Güler, Prof. Dr. Ali Fuat Yapar

47

The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer, BREAST, 54(0), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Alper Findikcioğlu, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan

48

Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse, LEUKEMIA RESEARCH, 41(6), 2020 SCI / SCI EXPANDED

50. Kose F, Alemdaroglu S, Besen Aa, Prof. Dr. Ozan Cem Güler, Mertsoylu H

49

Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension, Journal of BUON, 25(4), 2020 SCI / SCI EXPANDED

Fatih Kose 1, Songul Alemdaroglu, Huseyin Mertsoylu, Ali Ayberk Besen, Prof. Dr. Ozan Cem Güler

50

Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation, Journal of Applied Clinical Medical Physics, 21(9), 2020 SCI / SCI EXPANDED

59. Haciislamoglu E, Gungor G, Aydin G, Canyilmaz E, Prof. Dr. Ozan Cem Güler

51

National, Observational, Multicentric Retrospective Study to Understand Treatment Patterns, Patient Journey and Characteristics with Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial, International Journal of Hematology and Oncology, 108(3), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Demiral An, Atalar B, Prof. Dr. Ozan Cem Güler, Yalman D

52

Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Prof. Dr. Ozan Cem Güler, Hurmuz P, Torun N

53

Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002), STRAHLENTHERAPIE UND ONKOLOGIE, 196(11), 2020 SCI / SCI EXPANDED

Hurmuz P, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, İgdem S, Atalar B

54

Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients, Radiologia Medica, 125(8), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Bozca R, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G.

55

Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 40(7), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yildirim Ba, Gultekin M, Prof. Dr. Ozan Cem Güler

56

Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience, Journal of BUON, 25(5), 2020 SCI / SCI EXPANDED

Sezer A, Akkus B, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Sumbul At.

57

Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study, Journal of Oncology, 2020(0), 2020 SCI / SCI EXPANDED

Topkan E, Ozdemir Y, Prof. Dr. Ozan Cem Güler, Kucuk A, Besen Aa

58

Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy, Journal of Oncology, 2020(0), 2020 SCI / SCI EXPANDED

Topkan E, Ozdemir Y, Kucuk A, Prof. Dr. Ozan Cem Güler, Sezer A

59

Definitive concurrent chemoradiotherapy outcomes in Stage IIIB nonsmall cell lung cancer patients younger than 45 years: A retrospective analysis of 145 patients, Journal of Cancer Research and Therapeutics, 16(4), 2020 SCI / SCI EXPANDED

Prof. Dr. Erkan Topkan, Prof. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir

60

The effect of androgen deprivation therapy on Ga-68-PSMA tracer uptake in non-metastatic prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47(3), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar

61

Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30(6), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Gultekin M, Oymak E, Prof. Dr. Ozan Cem Güler, Yilmaz Mt

62

Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy, BREAST, 80(4), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yildirim Ba

63

Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(6), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Torun N, Oymak E, Prof. Dr. Ozan Cem Güler, Reyhan M

64

Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020 SCI / SCI EXPANDED

Doç. Dr. Neşe Torun, Gökhan Özyiğit, Prof. Dr. Ozan Cem Güler, Pervin Hürmüz, Murat Tuncer

65

Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(0), 2019 SCI / SCI EXPANDED

Doç. Dr. Neşe Torun, Meltem Çağlar, Fadıl Akyol, Prof. Dr. Ozan Cem Güler, Berna Akkuş Yıldırım

66

Prognostic values of ADCmean and SUVmax of the primary tumor in cervical cancer patients treated with definitive chemoradiotherapy., JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 0(0), 2019 SCI / SCI EXPANDED

56. Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Erbay G, Prof. Dr. Ozan Cem Güler, Karadeli E

67

Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients, Medical Dosimetry, 44(4), 2019 SCI / SCI EXPANDED

Yıldırım Ba, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G, Prof. Dr. Hüseyin Cem Önal

68

Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide, INDIAN JOURNAL OF CANCER, 56(1), 2019 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan

69

Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019 SCI / SCI EXPANDED

Ozyigit G, Prof. Dr. Hüseyin Cem Önal, Igdem S, Arican Alicikus Z, Iribas A

70

Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction, Clinical Breast Cancer, 19(5), 2019 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal

71

Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy, Current Medical Imaging Reviews, 33(3), 2019 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal

72

A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma, Journal of Gynecologic Oncology, 30(3), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yildirim Ba, Yavas G, Gultekin M

73

Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases, Journal of Bone Oncology, 15(0), 2019 SCI / SCI EXPANDED

Ozdemir Y, Torun N, Prof. Dr. Ozan Cem Güler, Yildirim Ba, Besen Aa

74

Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(1), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Akkus Yildirim B, Yuce Sari S, Yavas G, Gultekin M

75

Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019 SCI / SCI EXPANDED

66. Yildirim Ba, Prof. Dr. Hüseyin Cem Önal, Kose F, Oymak E, Sedef Am

76

The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 39(5), 2019 SCI / SCI EXPANDED

Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Fatih Köse, Prof. Dr. Hüseyin Cem Önal

77

Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(9), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Torun N, Akyol F, Prof. Dr. Ozan Cem Güler, Hurmuz P

78

Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery, IN VIVO, 33(6), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Efe E, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

79

Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), 2019 SCI / SCI EXPANDED

Gultekin M, Prof. Dr. Ozan Cem Güler, Guler Oc, Yuce Sari S, Akkus Yildirim B

80

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate., Future Oncology, 37(7), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sedef Am, Kose F, Oymak E, Prof. Dr. Ozan Cem Güler

81

Local Control and Vertebral Compression Fractures Following Stereotactic Body Radiotherapy for Spine Metastases, Journal of Bone Oncology, 24(15), 2019 SCI / SCI EXPANDED

Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Berna Akkuş, Ali Ayberk Beşen

82

Mide Kanserinde Definitif Radyoterapi. Üst Gastrointestinal Kanserlerde Radyoterapi. , Türkiye Klinikleri, 1(0), 2018 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

83

Outcomes of Treatment for Glioblastoma Multiforme in Adult Patients: A Single Institution Experience from the Eastern Black Sea Region of Turkey., International Journal of Hematology and Oncology, 0(0), 2018 SCI / SCI EXPANDED

Kandaz M, Bahat Z, Prof. Dr. Ozan Cem Güler, Canyılmaz E, Yazar U

84

Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide, JOURNAL OF NEURO-ONCOLOGY, 139(2), 2018 SCI / SCI EXPANDED

60. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Prof. Dr. Ozan Cem Güler

85

The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients, Clinical & Translational Oncology, 20(4), 2018 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Benedikt Engels, Prof. Dr. Hüseyin Cem Önal, Evaraert H, Van Den Begin R

86

Effect of adjuvant extended temozolamide treatment in survival of patients with glioblastoma multiforme, Cukurova Medical Journal, 43(3), 2018 SSCI

Yıldırım Ba, Su?Mbu?L At, Prof. Dr. Ozan Cem Güler, Sedef Am, Önal C

87

The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28(8), 2018 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yıldırım Ba., Prof. Dr. Ozan Cem Güler, Mertsoylu H

88

Prognostic role of pretreatment level hemoglobin levels in patients with local advanced rectum cancer treated with preoperative chemotherapy, Cukurova Medical Journal, 43(3), 2018 SSCI

Berna Akkuş Yıldırım1, Ahmet Taner Sümbül2, Prof. Dr. Ozan Cem Güler, Ali Murat Sedef4, Cem Önal1

89

Whole brain radiotherapy plus conventional boost in Non-Small Cell Lung Cancer Patients with brain metastasis: a retrospective analysis of overall survival., Turkish Neurosurgery, 0(0), 2018 SSCI

Kandaz M, Prof. Dr. Ozan Cem Güler, Yazar U, Cenyılmaz E, Yoney A

90

Responding to Veiga et al. 'Long term radiological features of radiation-induced lung damage', RADIOTHERAPY AND ONCOLOGY, 129(3), 2018 SCI / SCI EXPANDED

Oymak E, Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

91

Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer, LUNG CANCER, 121(0), 2018 SCI / SCI EXPANDED

57. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Prof. Dr. Ozan Cem Güler

92

Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem, ANNALS OF ONCOLOGY, 29(3), 2018 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Ozyar E

93

Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 39(6), 2018 SCI / SCI EXPANDED

Yıldırım Ba, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

94

Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(5), 2018 SCI / SCI EXPANDED

58. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Prof. Dr. Ozan Cem Güler

95

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients, Journal of Oncology, 2018(0), 2018 SCI / SCI EXPANDED

Topkan E, Selek U, Ozdemir Y, Besen Aa, Prof. Dr. Ozan Cem Güler

96

Radiotherapy in the management of classic Kaposi?xxs sarcoma: A single institution experience from Northeast Turkey, Dermatologic Therapy, 31(4), 2018 SCI / SCI EXPANDED

Kandaz M, Bahat Z, Prof. Dr. Ozan Cem Güler, Canyilmaz E, Melikoglu M

97

The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer, BRITISH JOURNAL OF RADIOLOGY, 90(1073), 2017 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Cengiz M, Prof. Dr. Ozan Cem Güler, Dolek Y, Ozkok S

98

Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?, Oncology Research and Treatment, 40(9), 2017 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Prof. Dr. Hüseyin Cem Önal, Yildiz F.

99

Malignant Mesenchymal Tumor of the Prostate: A Case Report., turkish journal of oncology, 0(0), 2017 SSCI

Kandaz M, Prof. Dr. Ozan Cem Güler, Karaman E, Mungan S, Yoney A:

100

Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27(7), 2017 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Sezin Yüce Sarı, Sumerya Duru Birgi, Melis Bahadır, Ferah Yıldız

101

Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images, ACTA RADIOLOGICA, 58(4), 2017 SCI / SCI EXPANDED

Prof. Dr. Gürcan Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Elif Karadeli, Prof. Dr. Ozan Cem Güler, Arica S

102

The effect of chemoradiotherapy at gastric cancer on pancreatic enzymes and pancreas volume., INTERNATIONAL JOURNAL OF HEMATOLOGY, 0(0), 2017 SCI / SCI EXPANDED

Kandaz M., Prof. Dr. Ozan Cem Güler, Yoney A.

103

Larinks Kanserinde Radyoterapi., Türkiye Klinikleri, 0(0), 2017 SSCI

Prof. Dr. Ozan Cem Güler, Canyılmaz E

104

Lokalize Prostat Kanserinde Radyoterapi, Türkiye Klinikleri, 0(0), 2017 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

105

Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy., JOURNAL OF MARINE RESEARCH, 0(0), 2017 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal

106

Prognostic Value of Pretreatment HER2 Status in Gastric Cancer Patients Treated with Postoperative Chemoradiotherapy, turkish journal of oncology, 0(0), 2017 SSCI

Prof. Dr. Ozan Cem Güler, Kandaz M, Bahat Z, Canyılmaz E, Çakır E

107

Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis, molecular and clinical oncology, 7(1), 2017 SSCI

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

108

Prognostic value of metabolic response measured by F-18-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 37(12), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

109

Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 14(2), 2016 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Nebil Bal, Prof. Dr. Hüseyin Cem Önal

110

Endometrial Adenosarcoma: Case Report, annals of clinical case reports, 1(1170), 2016 SSCI

Kandaz M, Karaman E, Prof. Dr. Ozan Cem Güler, Mungan S, Yoney A. :

111

Adjuvant radiotherapy in management of trichilemmal carcinoma of left nasal alae with positive surgical margins A case report, case reports in clinical pathology, 3(4), 2016 SSCI

Topkan E, Prof. Dr. Ozan Cem Güler, Bal N, Ozdemir Y:

112

High Prognostic Nutritional Index Relates with Enhanced Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy, Wulfenia, 0(0), 2016 SCI / SCI EXPANDED

Yıldırım Ba, Özdemir Y, Prof. Dr. Ozan Cem Güler, Prof. Dr. Erkan Topkan

113

Impact of Peritumoral Edema on Overall Survival in Glioblastoma Multiforme, turkish journal of oncology, 0(0), 2016 SSCI

Kandaz M, Prof. Dr. Ozan Cem Güler, Yazar U, Ucuncu Sy, Yoney A:

114

Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26(6), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

115

Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature, WIENER KLINISCHE WOCHENSCHRIFT, 128(7), 2016 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Müh. Güngör Arslan

116

Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF MAGNETIC RESONANCE IMAGING, 44(4), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler

117

Correlation of Clinical Risk Factors with Diffusion-Weighted Magnetic Resonance Images in Prostate Cancer Patients Treated with Definitive Radiotherapy, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 25(2), 2015 SCI / SCI EXPANDED

Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Elif Karadeli, Koc Z

118

Metastatik Evre ve Lokal Nükslerde Radyoterapi, Türkiye Klinikleri, 0(0), 2015 SSCI

Prof. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir, Prof. Dr. Hüseyin Cem Önal

119

The impact of air pockets around the vaginal cylinder on vaginal vault brachytherapy., Journal of Cancer Research and Therapeutics, 0(0), 2015 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y

120

Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(4), 2015 SCI / SCI EXPANDED

Prof. Dr. Erkan Topkan, Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Parlak C, Pehlivan B

121

Prognostic value of F-18-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy, GYNECOLOGIC ONCOLOGY, 137(1), 2015 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar

122

Uterine Perforation During 3-Dimensional Image-Guided Brachytherapy in Patients With Cervical Cancer Baskent University Experience, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 24(2), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y, Prof. Dr. Gürcan Erbay

123

Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 12(2), 2014 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Nebil Bal

124

Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer, Journal of Contemporary Brachytherapy, 6(4), 2014 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Acibuci İ

125

Hepatoselüer Karsinomda Radyoterapi, türkiye Klinikleri, 0(0), 2014 SSCI

Prof. Dr. Ozan Cem Güler

126

Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41(7), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ozan Cem Güler, Prof. Dr. Ali Fuat Yapar

127

Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy, BRITISH JOURNAL OF RADIOLOGY, 87(1034), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sonmez S, Erbay G, Prof. Dr. Ozan Cem Güler, Arslan G

128

Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 2014 SCI / SCI EXPANDED

Parlak C, Mertsoylu H, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan

129

Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenarians with stage IIIB non-small cell lung carcinoma: Retrospective analysis of 89 patients, LUNG CANCER, 81(2), 2013 SCI / SCI EXPANDED

54. Topkan E, Parlak C, Topuk S, Prof. Dr. Ozan Cem Güler, Selek U.:

130

PROGNOSTIC VALUE OF PRETREATMENT FDG UPTAKE IN CERVICAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23(8), 2013 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Parlak C, Prof. Dr. Ozan Cem Güler, Oymak E

Yayın ve Akademik Faaliyet Özeti